Disclosure Policy

Krebs Bankrott is committed to transparency and editorial independence, ensuring that our content remains unbiased and focused on the financial struggles of cancer patients and their caregivers in Germany. Established in 2018, our website has been dedicated to investigating the often-overlooked economic implications of cancer treatment, filling a gap left by clinical journals that rarely quantify these costs. Through our participation in reputable organizations such as Deutsche Krebshilfe, Verbraucherzentrale, and AOK, we strive to provide accurate and helpful information to those navigating the complexities of health finance.

Our audience, comprising cancer patients, caregivers, and health finance advocates aged 28-65, is at the forefront of our concerns. We recognize the importance of data privacy and adhere to strict policies to protect the personal information of our users. Key aspects of our disclosure policy include:

• Financial transparency regarding our operations and funding sources
• Clear differentiation between editorial content and any sponsored material
• Stringent data protection measures to safeguard user information

These principles guide our efforts to maintain trust and credibility with our readers.

As an advocacy-investigative platform, Krebs Bankrott is unique in its approach to quantifying the financial devastation of cancer treatment in Germany. Editorial independence is crucial to our mission, allowing us to pursue investigations without external influence. Data privacy is equally important, ensuring that users can engage with our content without concern for their personal information. For more details on our disclosure policy, funding, or to get in touch, please refer to our Contact Us page.